[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@jeno_long](/creator/twitter/jeno_long)
"@CathieDWood @ARKInvest @jimcramer @jeffmarkscnbc @ZevFima @MadMoneyOnCNBC #ICYMI: @PalantirTech and @Snowflake announced a partnership to integrate Snowflake's AI Data Cloud with Palantir Foundry and its Artificial Intelligence Platform (#AIP)"  
[X Link](https://x.com/jeno_long/status/1979248348566819272) [@jeno_long](/creator/x/jeno_long) 2025-10-17T18:09Z XXX followers, XX engagements


"@CathieDWood @ARKInvest @jimcramer @MadMoneyOnCNBC #ICYMI: @TuttleCapital is seeking to launch eight new ETFs focused on artificial intelligence including two thematic ETFs: $UFOD targeting companies with potential involvement in UFO-related technologies and $DPSK"  
[X Link](https://x.com/jeno_long/status/1892983450111479897) [@jeno_long](/creator/x/jeno_long) 2025-02-21T17:03Z XXX followers, XX engagements


"@CathieDWood @ARKInvest @elonmusk @jimcramer @jeffmarkscnbc @ZevFima @MadMoneyOnCNBC NEWS: @Stellantis and @PonyAI_tech have teamed up to develop and deploy robotaxis in European cities"  
[X Link](https://x.com/jeno_long/status/1979267592893444453) [@jeno_long](/creator/x/jeno_long) 2025-10-17T19:25Z XXX followers, XX engagements


"This collaboration will combine Stellantis' electric vehicle platforms with autonomous driving software to create an efficient and reliable fleet"  
[X Link](https://x.com/jeno_long/status/1979267596752163327) [@jeno_long](/creator/x/jeno_long) 2025-10-17T19:25Z XXX followers, XX engagements


"Real-world testing will begin in Luxembourg paving the way for competitive scalable autonomous mobility solutions across Europe. 📰👀 $STLA $PONY"  
[X Link](https://x.com/jeno_long/status/1979267601433026926) [@jeno_long](/creator/x/jeno_long) 2025-10-17T19:25Z XXX followers, XX engagements


"Timed to coincide with National HSA Awareness Day on October XX these tools aim to give consumers greater control over their health and finances amid rising medical costs. This reflects HealthEquitys commitment to expanding consumer-directed healthcare solutions"  
[X Link](https://x.com/jeno_long/status/1979227397087203385) [@jeno_long](/creator/x/jeno_long) 2025-10-17T16:45Z XXX followers, XX engagements


"@CathieDWood @ARKInvest @jimcramer @jeffmarkscnbc @ZevFima @MadMoneyOnCNBC NEWS: @GlaukosCorp has received FDA approval for #Epioxa the first incision-free topical drug therapy for keratoconus a rare sight-threatening eye disease that is often left undiagnosed and untreated"  
[X Link](https://x.com/jeno_long/status/1980327195009773667) [@jeno_long](/creator/x/jeno_long) 2025-10-20T17:36Z XXX followers, XX engagements


"Unlike traditional treatments Epioxa uses a UV-activated oxygen-enriched riboflavin formula that strengthens the cornea without surgery. This non-invasive approach offers a safer more comfortable alternative to corneal transplants by minimizing patient pain and"  
[X Link](https://x.com/jeno_long/status/1980327198126141599) [@jeno_long](/creator/x/jeno_long) 2025-10-20T17:36Z XXX followers, XX engagements